Real-world clinical and economic outcomes among persons with multiple sclerosis initiating first- vs second-line treatment with ocrelizumabC. Geiger,D. Sheinson, T. M. To,D. Jones, N. BonineMULTIPLE SCLEROSIS JOURNAL（2022）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
